Schedule 13G ownership disclosure

TCR2 THERAPEUTICS INC

Security class unavailable · CUSIP: 87808K106

Event date: 2019-02-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-19-009313
Form type
SC 13G
Filer
Redmile Group, LLC
CIK
CIK 1425738
Filed
Feb 21, 2019
Reporting period
Feb 19, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub